EFTUD2 and neoplasm: Here, we found that low StromalScore, ImmuneScore, and ESTIMATEScore values and high TumorPurity scores were associated with poor LUAD prognosis, indicating that EFTUD2 overexpression may shape a microenvironment detrimental to LUAD prognosis through alterations in immune, stromal, and tumor cell abundance.